Bridging-to-Transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-Host Disease

Koichi Murakami; Hironori Ueno; Takashi Okabe; Toshiya Kagoo; Saigen Boku; Takahiro Yano; Akihiro Yokoyama (2017). Bridging-to-Transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-Host Disease. Hematology Reports, 9(2), 7114. https://doi.org/10.4081/hr.2017.7114